[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
July 1, 2009

Adverse Outcomes Associated With Use of Proton Pump Inhibitors and Clopidogrel—Reply

JAMA. 2009;302(1):29-31. doi:10.1001/jama.2009.900

In Reply: We agree with Drs Chae and Kim that some PPIs may not be associated with attenuation of the benefits of clopidogrel. In our study, the majority of patients were prescribed omeprazole and, to a smaller extent, rabeprazole. Thus, the results are primarily referable to these agents.

Chae and Kim cite the ACCF/ACG/AHA consensus statement on reducing gastrointestinal risks of antiplatelet therapy and NSAID use. This statement recommended that patients taking dual antiplatelet therapy should be prescribed a PPI medication in the presence of specific risk factors.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×